Pharmafile Logo
Pharmafocus logo
Advanced Search

Infectious diseases versus clinical researchers. Who is winning?

November 16, 2011
Research and Development

They were running hand in hand, and the Queen went so fast that it was all she could do to …

Feature
Thought Leadership

Full service CROs: a cost-effective option for global therapeutically focused clinical development expertise

November 16, 2011
Research and Development

Skyrocketing clinical development costs are bad news for everyone, from pharmaceutical companies to patients. That’s why it’s crucial we find …

Feature
Thought Leadership

Emerging markets: comparing India and China as the future R&D hubs for the pharmaceutical industry

November 16, 2011
Research and Development

The pharmaceutical industry is expanding worldwide. For the last few years, the emerging markets that offer the dynamics of growth …

Feature
Thought Leadership
Boehringer pic

Boehringer invests $65 million in early R&D centre

November 16, 2011
Research and Development, Sales and Marketing Boehringer Ingelheim

Boehringer Ingelheim is investing $65 million for an early-stage research and development centre in the US. The new 72,000 sq.ft. …

News

Pharmacovigilance in the EU – recent and future changes

November 15, 2011
Research and Development

Changes to both post-marketing and clinical trial requirements

Feature
Thought Leadership
Boehringer Facebook image

Boehringer developing Facebook game

November 15, 2011
Medical Communications Boehringer Ingelheim, Facebook

Boehringer Ingelheim is developing a new Facebook civilisation game in the hopes of helping the public understand the difficulty involved …

News

The roles and responsibilities of an EEA qualified person for pharmacovigilance (QPPV)

November 15, 2011
Research and Development

The roles and responsibilities of an EEA Qualified Person for Pharmacovigilance are based on the current Directive 2001/83/EC and Vol …

Feature
Thought Leadership

Merck’s vorapaxar fails in late-stage trial

November 15, 2011
ACS, Brilinta, Efient, Merck, Plavix, antiplatelet, vorapaxar

Merck’s novel blood thinner vorapaxar has failed to meet its primary endpoint in a late-stage study.The TRACER trial compared vorapaxar …

News

UCB will double staff at Swiss bioproduction facility

November 15, 2011
Manufacturing and Production UCB, manufacturing

Belgian pharmaceutical company UCB showcased its new bioproduction facility in Bulle, Switzerland, yesterday, saying that the workforce there looks set …

News

Joachim Christ to lead corporate controlling at Merck KGaA

November 15, 2011
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Merck KGaA

Joachim Christ will join Merck KGaA on 1 January next year as its new head of corporate controlling. Christ, 46, …

Appointment

China’s SFDA starts overseas inspections

November 15, 2011
Manufacturing and Production China, SFDA, manufacturing and production

China’s State Food and Drug Administration (SFDA) has started to inspect overseas manufacturing facilities in yet another sign of the …

News

Sanofi’s Lemtrada beats Rebif in new study

November 14, 2011
Research and Development, Sales and Marketing Lemtrada, Rebif, Sanofi

Lemtrada has beaten Merck Serono’s multiple sclerosis treatment Rebif in a new head-to-head trial, paving the way for regulatory submission …

News
mark_greener_21

Mark Greener appointed editorial director at Rock Medical Communications

November 14, 2011
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Mark Greener, Rock Medical Communications

Rock medical communications has appointed journalist and medical writer Mark Greener as editorial director.  Mark spent a decade in the …

Appointment

The ABPI’s new leader: communicating pharma’s value

November 14, 2011
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Stephen Whitehead

When Richard Barker, the ABPI’s director general decided to step down in May this year after six and a half …

Feature

BMS boosts access to HIV drug Reyataz in Brazil

November 14, 2011
Manufacturing and Production, Sales and Marketing

Bristol-Myers Squibb has signed a technology transfer agreement with the Brazilian Ministry of Health to expand access to once-daily HIV …

News

Medical meetings and events – how to make the most of your budget

November 14, 2011
Sales and Marketing

 In today’s uncertain economic climate, much like every other form of marketing and business expenditure, event budgets are under scrutiny …

Feature
Thought Leadership

Eliquis fails in head-to-head study against Lovenox

November 14, 2011
Research and Development, Sales and Marketing BMS, Eliquis, Lovenox, Pfizer

Bristol-Myers Squibb and Pfizer have suffered a setback in their attempts to cement Eliquis’ place in the $20 billion market …

News
wellspring_ontario_facility

CMO WellSpring brought by private equity firms

November 14, 2011
Manufacturing and Production

WellSpring Pharmaceutical Corp has been acquired by private equity group Ancor Capital Partners in a deal which looks set to …

News

Genzyme appoints new leaders for multiple sclerosis and rare disease businesses

November 14, 2011
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Genzyme

Genzyme, a Sanofi company, has appointed William Sibold as head of multiple sclerosis and Rogério Vivaldi as head of rare …

Appointment

Xarelto succeeds in new study

November 14, 2011
Sales and Marketing Bayer, FDA, J&J, JJ, Xarelto

In a new study J&J and Bayer’s blood thinner Xarelto reduced deaths in patients after a heart attack, which could …

News
The Gateway to Local Adoption Series

Latest content

Rentschler Biopharma appoints Uwe Buecheler as interim CEO

January 26, 2026

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026